Welch & Forbes LLC grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 96.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 35,556 shares of the semiconductor company’s stock after acquiring an additional 17,481 shares during the period. Welch & Forbes LLC’s holdings in Synopsys were worth $16,701,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the business. Impact Partnership Wealth LLC bought a new position in shares of Synopsys during the fourth quarter valued at $291,000. Norges Bank bought a new position in shares of Synopsys during the fourth quarter valued at $730,197,000. Amica Mutual Insurance Co. raised its stake in shares of Synopsys by 31.8% during the fourth quarter. Amica Mutual Insurance Co. now owns 8,172 shares of the semiconductor company’s stock valued at $3,839,000 after acquiring an additional 1,970 shares during the last quarter. Zweig DiMenna Associates LLC bought a new position in shares of Synopsys during the fourth quarter valued at $10,804,000. Finally, Eurizon Capital SGR S.p.A. bought a new position in shares of Synopsys during the fourth quarter valued at $15,662,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $475.62 on Friday. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The firm has a fifty day simple moving average of $459.53 and a 200 day simple moving average of $454.45. The company has a market capitalization of $91.07 billion, a PE ratio of 110.10, a P/E/G ratio of 3.90 and a beta of 1.25. The company has a quick ratio of 1.26, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. Morgan Stanley raised their price target on shares of Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research note on Thursday. Bank of America lifted their target price on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday. Piper Sandler lifted their target price on shares of Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday. The Goldman Sachs Group set a $600.00 target price on shares of Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Finally, Stifel Nicolaus lifted their target price on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $563.81.
Check Out Our Latest Stock Analysis on Synopsys
Trending Headlines about Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys said demand for AI chip design software is driving stronger business momentum, and it raised its annual forecast as a result. Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: The CFO highlighted that AI companies are increasingly using custom computer designs, a trend that could expand demand for Synopsys’ chip-design tools. AI Computer Design Diversity A Boon For Synopsys, Says CFO
- Positive Sentiment: Analysts raised price targets after the earnings report, signaling confidence in Synopsys’ longer-term growth outlook despite the stock’s recent weakness. Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Positive Sentiment: Synopsys also showcased new AI and multi-die design capabilities with Samsung Foundry, underscoring its role in advanced chip development. Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026
- Neutral Sentiment: The company beat fiscal Q2 estimates, with revenue up 41.9% year over year and EPS above expectations, but the market still sold the stock after the report. Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus
- Negative Sentiment: Investors appear wary about the company’s chip-IP business and the broader impact of integrating Ansys, which may be weighing on sentiment even after strong results. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
